These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 35527168

  • 1. IL-6 and its role in IgA nephropathy development.
    Groza Y, Jemelkova J, Kafkova LR, Maly P, Raska M.
    Cytokine Growth Factor Rev; 2022 Aug; 66():1-14. PubMed ID: 35527168
    [Abstract] [Full Text] [Related]

  • 2. IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells.
    Novak J, Raskova Kafkova L, Suzuki H, Tomana M, Matousovic K, Brown R, Hall S, Sanders JT, Eison TM, Moldoveanu Z, Novak L, Novak Z, Mayne R, Julian BA, Mestecky J, Wyatt RJ.
    Nephrol Dial Transplant; 2011 Nov; 26(11):3451-7. PubMed ID: 21828345
    [Abstract] [Full Text] [Related]

  • 3. Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease.
    Reily C, Ueda H, Huang ZQ, Mestecky J, Julian BA, Willey CD, Novak J.
    J Immunol Res; 2014 Nov; 2014():197548. PubMed ID: 25152896
    [Abstract] [Full Text] [Related]

  • 4. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
    Novak J, Moldoveanu Z, Julian BA, Raska M, Wyatt RJ, Suzuki Y, Tomino Y, Gharavi AG, Mestecky J, Suzuki H.
    Adv Otorhinolaryngol; 2011 Nov; 72():60-3. PubMed ID: 21865691
    [Abstract] [Full Text] [Related]

  • 5. TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-mediated pathways in IgA nephropathy.
    Makita Y, Suzuki H, Kano T, Takahata A, Julian BA, Novak J, Suzuki Y.
    Kidney Int; 2020 Feb; 97(2):340-349. PubMed ID: 31748116
    [Abstract] [Full Text] [Related]

  • 6. Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.
    Liu Y, Li H, Yu H, Wang F, Jia J, Yan T.
    BMC Nephrol; 2022 Jan 11; 23(1):25. PubMed ID: 35016642
    [Abstract] [Full Text] [Related]

  • 7. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
    Moura IC, Arcos-Fajardo M, Gdoura A, Leroy V, Sadaka C, Mahlaoui N, Lepelletier Y, Vrtovsnik F, Haddad E, Benhamou M, Monteiro RC.
    J Am Soc Nephrol; 2005 Sep 11; 16(9):2667-76. PubMed ID: 15987753
    [Abstract] [Full Text] [Related]

  • 8. Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.
    Zhao YF, Zhu L, Liu LJ, Shi SF, Lv JC, Zhang H.
    BMC Nephrol; 2017 Sep 29; 18(1):301. PubMed ID: 28969604
    [Abstract] [Full Text] [Related]

  • 9. Sparsentan ameliorates glomerular hypercellularity and inflammatory-gene networks induced by IgA1-IgG immune complexes in a mouse model of IgA nephropathy.
    Reily C, Moldoveanu Z, Pramparo T, Hall S, Huang ZQ, Rice T, Novak L, Komers R, Jenkinson CP, Novak J.
    Am J Physiol Renal Physiol; 2024 May 01; 326(5):F862-F875. PubMed ID: 38511222
    [Abstract] [Full Text] [Related]

  • 10. Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors.
    Zachova K, Jemelkova J, Kosztyu P, Ohyama Y, Takahashi K, Zadrazil J, Orsag J, Matousovic K, Galuszkova D, Petejova N, Mestecky J, Raska M.
    J Am Soc Nephrol; 2022 May 01; 33(5):908-917. PubMed ID: 35115327
    [Abstract] [Full Text] [Related]

  • 11. Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy.
    Cambier A, Gleeson PJ, Abbad L, Canesi F, da Silva J, Bex-Coudrat J, Deschênes G, Boyer O, Rabant M, Ulinski T, Hogan J, Peuchmaur M, Berthelot L, Monteiro RC.
    Kidney Int; 2022 Feb 01; 101(2):274-287. PubMed ID: 34756952
    [Abstract] [Full Text] [Related]

  • 12. Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1.
    Ebefors K, Liu P, Lassén E, Elvin J, Candemark E, Levan K, Haraldsson B, Nyström J.
    BMC Nephrol; 2016 Apr 05; 17():40. PubMed ID: 27044423
    [Abstract] [Full Text] [Related]

  • 13. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells.
    Novak J, Tomana M, Matousovic K, Brown R, Hall S, Novak L, Julian BA, Wyatt RJ, Mestecky J.
    Kidney Int; 2005 Feb 05; 67(2):504-13. PubMed ID: 15673298
    [Abstract] [Full Text] [Related]

  • 14. LPS/TLR4 Pathway Regulates IgA1 Secretion to Induce IgA Nephropathy.
    He H, Shen M, Tang Y, Sun W, Xu X.
    Altern Ther Health Med; 2024 Jan 05; 30(1):419-425. PubMed ID: 37820669
    [Abstract] [Full Text] [Related]

  • 15. Glomerular galactose-deficient IgA1 expression analysis in pediatric patients with glomerular diseases.
    Ishiko S, Horinouchi T, Fujimaru R, Shima Y, Kaito H, Tanaka R, Ishimori S, Kondo A, Nagai S, Aoto Y, Sakakibara N, Nagano C, Yamamura T, Yoshimura M, Nakanishi K, Fujimura J, Kamiyoshi N, Nagase H, Yoshikawa N, Iijima K, Nozu K.
    Sci Rep; 2020 Aug 20; 10(1):14026. PubMed ID: 32820208
    [Abstract] [Full Text] [Related]

  • 16. Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
    Wada Y, Matsumoto K, Suzuki T, Saito T, Kanazawa N, Tachibana S, Iseri K, Sugiyama M, Iyoda M, Shibata T.
    PLoS One; 2018 Aug 20; 13(11):e0206865. PubMed ID: 30388165
    [Abstract] [Full Text] [Related]

  • 17. Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.
    Novak J, Barratt J, Julian BA, Renfrow MB.
    Semin Nephrol; 2018 Sep 20; 38(5):461-476. PubMed ID: 30177018
    [Abstract] [Full Text] [Related]

  • 18. Glomerular deposition of galactose-deficient IgA1-containing immune complexes via glomerular endothelial cell injuries.
    Makita Y, Suzuki H, Nakano D, Yanagawa H, Kano T, Novak J, Nishiyama A, Suzuki Y.
    Nephrol Dial Transplant; 2022 Aug 22; 37(9):1629-1636. PubMed ID: 35746884
    [Abstract] [Full Text] [Related]

  • 19. Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy.
    Zhang K, Li Q, Zhang Y, Shang W, Wei L, Li H, Gao S, Yan T, Jia J, Liu Y, Lin S.
    Kidney Blood Press Res; 2019 Aug 22; 44(5):1196-1206. PubMed ID: 31574506
    [Abstract] [Full Text] [Related]

  • 20. Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy.
    Moldoveanu Z, Suzuki H, Reily C, Satake K, Novak L, Xu N, Huang ZQ, Knoppova B, Khan A, Hall S, Yanagawa H, Brown R, Winstead CJ, O'Quinn DB, Weinmann A, Gharavi AG, Kiryluk K, Julian BA, Weaver CT, Suzuki Y, Novak J.
    J Autoimmun; 2021 Mar 22; 118():102593. PubMed ID: 33508637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.